Preparation of polyclonal antibodies for nateglinide (NTG) and development of a sensitive chemiluminescent immunoassay to detect NTG in tablets and serum
Preparation of polyclonal antibodies for nateglinide (NTG) and development of a sensitive chemiluminescent immunoassay to detect NTG in tablets and serum
复制标题
那格列奈 (NTG) 多克隆抗体的制备以及检测片剂和血清中 NTG 的灵敏化学发光免疫分析方法的开发
DOI:
10.1016/j.talanta.2015.09.008
复制
发表时间:
2015
期刊:
影响因子:
6.1
通讯作者:
Xi Rimo
中科院分区:
文献类型:
--
作者:
Zheng Lei;Wang Jing;Zhang Jie;Song Zhaorui;Dong Yaqing;Wang Yufen;Tong Zhongsheng;Deng Chuan;Yin Yongmei;Meng Meng;Xi Rimo
In this study, we prepared polyclonal antibodies against anti-diabetic drug nateglinide (NTG), and established a sensitive chemiluminescent immunoassay (CLIA) to detect NTG in tablets and serum. Two kinds of immunogens were synthesized using ethylcarbodiimide (EDC)/hydroxysuccinimide (NHS) and carbonyldiimidazole (CDI)/4-dimethylaminopyridine (DMAP) as coupling reagents respectively. When activated by EDC/NHS, more molecules of NTG coupled with carrier protein in immunogens. A horseradish peroxidase (HRP)-luminol-H2O2system withp-iodophenol enhancement was applied in the CLIA analysis. The antibodies in EDC/NHS group showed higher titer, sensitivity and wider detection linear range than those in CDI/DMAP group, and were chosen for next studies. The developed CLIA assay exhibited good selectivity towards NTG among structually similar analogs. The method could detect as low as 0.35 ng mL−1NTG in buffer, 2.1 ng mL−1NTG in serum and 0.84 ng mL−1NTG in tablets. The CLIA method provided consistent results with HPLC method (r=0.9986) in determination of NTG from 5.0 to 400 µg mL−1. The CLIA method could detect 78 samples in one assay, and the samples need only dilution in pretreatment. As a summary, this research offers a sensitive assay for high-throughout screening of NTG in formulation control and pharmacokinetic studies.